Martin Shkreli Goes on Tweet Rampage After Teens' Drug Discovery
Shkreli came to fame for hiking a malaria drug by 5,000%.
@nedavanovac lol how is that showing anyone up? almost any drug can be made at small scale for a low price. glad it makes u feel good tho.— Martin Shkreli (@MartinShkreli) December 1, 2016
Despite being a former hedge fund manager and the owner of Turing Pharmaceuticals, looks like Shkreli can't take a little competition. Shkreli came to fame a few years ago when, as a new owner of Turing Pharmaceuticals, he raised the price of Daraprim, a drug used to treat malaria, by 5,000%. The $13.50 dose went to $750 for US consumers.
This week, students in 11th grade in Australia created the same life-saving drug in their school laboratory for just $2. After journalist Neda Vanovac congratulated the boys on Twitter, many renewed their criticisms of Shkreli, and he struck back with a slew of tweets criticizing and diminishing the students' accomplishment.
i'm a grown ass man & want to introduce these kids to the concept that average ANDA takes 5 years & costs $5m. so they have $4,999,980 to go https://t.co/vUsV6DxFVB— Martin Shkreli (@MartinShkreli) December 1, 2016
I'm "dragging" the adults, like you, who are using them to extend an incorrect and misleading narrative. https://t.co/cLDjS3rQdJ— Martin Shkreli (@MartinShkreli) December 1, 2016
And never, ever compare your cook game to mine. Highest yield, best purity, most scale. I have the synthesis game on lock.— Martin Shkreli (@MartinShkreli) December 1, 2016
Australians mostly calling in to apologize on behalf of their country. LOL.— Martin Shkreli (@MartinShkreli) December 2, 2016
But the Australian students took it all in good stride.
“Saying to us that anyone could do what we could do is certainly true,” Leonard Milan, one of the students, told the Guardian Australia. “But the fact that we were able to substitute some really toxic gasses with simple school-available chemicals and do it so cheaply demonstrates the absurdity of some of his justifications for the price.”
Dr. Alice Williamson, who guided the experiment, explained that showing how inexpensive and easy the drug was to produce, and in turn highlighting how unfair Shkreli’s up-hikes in price are was part of the point of the project.
If having their voices heard was the aim, it’s clear the Internet has made the highlighting of unfair drug prices a success. The story went global overnight, as the US edition of the Guardian picked up the piece.
Shkreli did not find any amusement in the popularity of the piece, and succumbed to taking out his anger on journalists.
These kids who 'made Daraprim' reminds me of Ahmed who 'made the clock'. Dumb journalists want a feel good story.— Martin Shkreli (@MartinShkreli) December 1, 2016
Shkreli then seemed to have reconsidered his response and he put out this strange, seemingly scripted video.
Though most of the short clip emphasizes Shkreli’s boasting about his own achievements, he saves a few seconds to delight in the news of young students pursuing STEM.
Unfortunately, the students are not be able to sell the drug in the United States because Turing still has exclusive rights to it. However, the awareness raised on the absurdity of Shkreli’s price hike is clearer than ever thanks to this group of high school students.
But have no fear because Shkreil’s crudeness is being used as further motivation by the students. They told the Guardian that the project had instilled a passion in them for science, and it’s clear to us that the experience has taught them ethics alongside STEM.
11 Inspirational Stephen Hawking Quotes That Will Fill You With Wonder
Stephen Hawking was more than a global citizen — he was a citizen of the universe. Read More
These 7 Countries Eliminated a Neglected Tropical Disease in 2017 — and More Will Follow in 2018
These diseases are deadly and debilitating. But they are also entirely preventable. Read More
This Is What It's Like to Be a Midwife in a Rohingya Refugee Camp
Tania Akter is caring for some of the most vulnerable women in the world. Read More